1. Home
  2. PSTV vs UPXI Comparison

PSTV vs UPXI Comparison

Compare PSTV & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • UPXI
  • Stock Information
  • Founded
  • PSTV 1996
  • UPXI 2018
  • Country
  • PSTV United States
  • UPXI United States
  • Employees
  • PSTV N/A
  • UPXI N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • UPXI Medicinal Chemicals and Botanical Products
  • Sector
  • PSTV Health Care
  • UPXI Health Care
  • Exchange
  • PSTV Nasdaq
  • UPXI Nasdaq
  • Market Cap
  • PSTV 9.9M
  • UPXI 8.5M
  • IPO Year
  • PSTV N/A
  • UPXI 2021
  • Fundamental
  • Price
  • PSTV $1.75
  • UPXI $0.40
  • Analyst Decision
  • PSTV Strong Buy
  • UPXI Hold
  • Analyst Count
  • PSTV 1
  • UPXI 1
  • Target Price
  • PSTV $8.00
  • UPXI $1.25
  • AVG Volume (30 Days)
  • PSTV 64.4K
  • UPXI 96.6K
  • Earning Date
  • PSTV 08-12-2024
  • UPXI 07-09-2024
  • Dividend Yield
  • PSTV N/A
  • UPXI N/A
  • EPS Growth
  • PSTV N/A
  • UPXI N/A
  • EPS
  • PSTV N/A
  • UPXI N/A
  • Revenue
  • PSTV $6,084,000.00
  • UPXI $81,433,807.00
  • Revenue This Year
  • PSTV $5.21
  • UPXI $18.98
  • Revenue Next Year
  • PSTV N/A
  • UPXI $8.09
  • P/E Ratio
  • PSTV N/A
  • UPXI N/A
  • Revenue Growth
  • PSTV 733.42
  • UPXI 16.95
  • 52 Week Low
  • PSTV $0.97
  • UPXI $0.34
  • 52 Week High
  • PSTV $3.21
  • UPXI $2.29
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 47.92
  • UPXI 43.50
  • Support Level
  • PSTV $1.62
  • UPXI $0.40
  • Resistance Level
  • PSTV $1.92
  • UPXI $0.45
  • Average True Range (ATR)
  • PSTV 0.18
  • UPXI 0.04
  • MACD
  • PSTV 0.02
  • UPXI 0.00
  • Stochastic Oscillator
  • PSTV 52.24
  • UPXI 40.49

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About UPXI Upexi Inc.

Upexi Inc is an innovator in aggregation, accelerating Amazon and eCommerce businesses by combining consumer data and vertical integration to scale brands in multiple industries, while lowering costs with a growing distribution network.

Share on Social Networks: